Malignant Peripheral Nerve Sheath Tumors
📧 Sign up to get email alerts when something new happens for Malignant Peripheral Nerve Sheath Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors
A multi-institutional registry study is currently recruiting participants to study malignant peripheral nerve sheath tumors.
-
CLINICAL_TRIALS trial_result · 2019-05-02Clinical Trial Update: SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors) [Phase 1, Phase 2]
Clinical trial update for SARC023 evaluating ganetespib and sirolimus in malignant peripheral nerve sheath tumors (MPNST) across Phase 1 and…
-
CLINICAL_TRIALS trial_result · 2019-03-06Clinical Trial Update: SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors [Phase 2]
Phase 2 study evaluating everolimus with bevacizumab for refractory malignant peripheral nerve sheath tumors has completed with posted resul…
-
CLINICAL_TRIALS trial_result · 2018-11-23Clinical Trial Update: Trial of Dasatinib in Advanced Sarcomas [Phase 2]
Phase 2 trial update for dasatinib in advanced sarcomas, with completed status and results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2012-08-07Clinical Trial Update: Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors [Phase 2, Phase 3]
A Phase 2/3 trial evaluating Imatinib Mesylate for malignant peripheral nerve sheath tumors has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.